We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+31.12%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$3.04B
AUM Growth
+$2.08B
Cap. Flow
+$1.67B
Cap. Flow %
55.04%
Top 10 Hldgs %
26.16%
Holding
518
New
283
Increased
39
Reduced
50
Closed
120

Top Buys

Rank Stock Value
1
AAL icon
American Airlines Group
AAL
+$99.6M
2
TMUS icon
T-Mobile US
TMUS
+$89.9M
3
PCG icon
PG&E
PCG
+$79.7M
4
OKE icon
Oneok
OKE
+$68.2M
5
TME icon
Tencent Music
TME
+$59.9M

Sector Composition

Rank Sector Weight
1 Communication Services 9.75%
2 Healthcare 9.36%
3 Industrials 8.38%
4 Technology 7.16%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONEM
301
DELISTED
1Life Healthcare
ONEM
$533K 0.02%
14,678
-322
-2% -$9.07K
RETA
302
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$530K 0.02%
3,400
+1,400
+70% +$213K
NVCR icon
303
PUT
NovoCure
NVCR
$1.73B
$528K 0.02%
+8,900
New +$585K
APT icon
304
CALL
Alpha Pro Tech
APT
$50.4M
$527K 0.02%
29,800
+1,300
+5% +$18K
XLNX
305
PUT
DELISTED
Xilinx Inc
XLNX
$512K 0.02%
5,200
-4,700
-47% -$417K
BIIB icon
306
CALL
Biogen
BIIB
$30B
$508K 0.02%
1,900
-500
-21% -$150K
LVS icon
307
CALL
Las Vegas Sands
LVS
$31.7B
$483K 0.02%
10,600
-29,900
-74% -$1.4M
KHC icon
308
CALL
Kraft Heinz
KHC
$30.7B
$482K 0.02%
15,100
+12,700
+529% +$381K
BCRX icon
309
CALL
BioCryst Pharmaceuticals
BCRX
$2.28B
$476K 0.02%
+99,900
New +$399K
SHOP icon
310
CALL
Shopify
SHOP
$152B
$475K 0.02%
5,000
-119,000
-96% -$8.26M
DLTR icon
311
CALL
Dollar Tree
DLTR
$24.4B
$473K 0.02%
+5,100
New +$425K
BA icon
312
Boeing
BA
$171B
$472K 0.02%
+2,573
New +$395K
SYY icon
313
PUT
Sysco
SYY
$40.8B
$465K 0.02%
+8,500
New +$447K
CCL icon
314
PUT
Carnival Corporation Ltd
CCL
$38.1B
$460K 0.02%
+28,000
New +$420K
BOC icon
315
Boston Omaha
BOC
$428M
$449K 0.01%
+28,084
New +$469K
ALGN icon
316
PUT
Align Technology
ALGN
$12.1B
$439K 0.01%
+1,600
New +$360K
REGN icon
317
Regeneron Pharmaceuticals
REGN
$78.5B
$437K 0.01%
+700
New +$397K
RNAM
318
DELISTED
Avidity Biosciences
RNAM
$424K 0.01%
+15,000
New +$432K
ORIC icon
319
Oric Pharmaceuticals
ORIC
$1.15B
$422K 0.01%
+12,500
New +$399K
TGT icon
320
PUT
Target
TGT
$65.6B
$420K 0.01%
3,500
-45,500
-93% -$5.19M
EXAS
321
CALL
DELISTED
Exact Sciences
EXAS
$417K 0.01%
+4,800
New +$384K
NEM icon
322
CALL
Newmont
NEM
$98.7B
$414K 0.01%
6,700
-68,300
-91% -$4.04M
DFS
323
CALL
DELISTED
Discover Financial Services
DFS
$411K 0.01%
+8,200
New +$361K
AGNC icon
324
CALL
AGNC Investment
AGNC
$12.4B
$408K 0.01%
31,600
-58,400
-65% -$733K
NVRO
325
PUT
DELISTED
NEVRO CORP.
NVRO
$394K 0.01%
+3,300
New +$391K

Similar funds

CAAS Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, CAAS Capital Management held 518 positions worth $3.04B, up 218% from $958M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

CAAS Capital Management deployed $1.67B of net new capital in Q2 2020, opening 283 new positions and adding to 39 existing holdings. Its largest new stake was American Airlines Group: 8,214,200 shares worth $107M.

By sector, the portfolio is most concentrated in Communication Services at 9.7% of assets, up from 4.3% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was ServiceNow, an estimated $5.65M trimmed.

  • CAAS Capital Management's largest Q2 2020 buy was American Airlines Group: 8,214,200 shares worth $107M.
  • CAAS Capital Management added most to US Steel in Q2 2020, an estimated $46.9M increase.
  • CAAS Capital Management's biggest Q2 2020 reduction was ServiceNow, cutting an estimated $5.65M.
  • CAAS Capital Management fully exited RTX Corp in Q2 2020, selling an estimated $45.5M.
  • CAAS Capital Management's ten largest holdings make up 26% of its $3.04B portfolio in Q2 2020.
  • CAAS Capital Management opened 283 new positions and closed 120 in Q2 2020.
  • CAAS Capital Management's portfolio value rose 218% quarter-over-quarter to $3.04B.

Based on CAAS Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.